Opioid-related risk perceptions in chronic pain: influence of patient gender and previous misuse behaviors.
Journal
Pain
ISSN: 1872-6623
Titre abrégé: Pain
Pays: United States
ID NLM: 7508686
Informations de publication
Date de publication:
01 04 2022
01 04 2022
Historique:
received:
02
02
2021
accepted:
07
07
2021
pubmed:
22
7
2021
medline:
20
4
2022
entrez:
21
7
2021
Statut:
ppublish
Résumé
Little is known about the factors that influence providers' perceptions of patient risk for aberrant opioid use. Patient gender may interact with previous opioid misuse to influence these perceptions. We asked 131 physicians to view videos and vignettes for 8 virtual patients with chronic pain. Gender (male/female) and previous prescription opioid misuse (present/absent) varied across patients; the vignettes were otherwise balanced on demographic and clinical characteristics. For each patient, providers assessed 4 risk domains: opioid-related adverse events, opioid misuse or abuse, opioid addiction, and opioid diversion. Results indicated a significant gender-by-misuse interaction for risk of opioid misuse orabuse. When previous misuse behaviors were absent, providers rated men at higher risk; there was no gender difference when previous misuse behaviors were present. A significant gender-by-misuse interaction was found for risk of opioid-related adverse events. Providers perceived men to be at higher risk when previous misuse behaviors were absent; there was no gender difference when previous misuse behaviors were present. A significant gender-by-misuse interaction was found for risk of opioid addiction. Providers rated women at higher risk when previous misuse behaviors were present and men at higher risk when previous misuse behaviors were absent. There were significant main effects of gender and misuse for risk of opioid diversion. Providers rated men and those with previous misuse behaviors at higher risk. These results demonstrate that patient gender and previous opioid misuse have unique and interactive effects on provider perceptions of prescription opioid-related risks. Studies are needed to identify the mechanisms underlying these effects, such as gender-based stereotypes about risk-taking and drug abuse.
Identifiants
pubmed: 34285152
doi: 10.1097/j.pain.0000000000002412
pii: 00006396-202204000-00010
pmc: PMC8761212
mid: NIHMS1724865
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
711-718Subventions
Organisme : NIMHD NIH HHS
ID : R01 MD008931
Pays : United States
Informations de copyright
Copyright © 2021 International Association for the Study of Pain.
Références
Alqudah AF, Hirsh AT, Stutts LA, Scipio CD, Robinson ME. Sex and race differences in rating others' pain, pain-related negative mood, pain coping, and recommending self-help. J Cyber Ther Rehabil 2010;3:63–70.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington: American Psychiatric Publishing, 2013.
Anastas TM, Miller MM, Hollingshead NA, Stewart JC, Rand KL, Hirsh AT. The unique and interactive effects of patient race, patient socioeconomic status, and provider attitudes on chronic pain care decisions. Ann Behav Med 2020;54:771–82.
Back SE, Payne RL, Simpson AN, Brady KT. Gender and prescription opioids: findings from the national survey on drug use and health. Addict Behav 2010;35:1001–7.
Banta-Green CJ, Merrill JO, Doyle SR, Boudreau DM, Calsyn DA. Opioid use behaviors, mental health and pain—development of a typology of chronic pain patients. Drug Alcohol Depend 2009;104:34–42.
Becker WC, Sullivan LE, Tetrault JM, Desai RA, Fiellin DA. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend 2008;94:38–47.
Biernat M, Manis M, Nelson TE. Stereotypes and standards of judgment. J Pers Soc Psychol 1991;60:485–99.
Carise D, Dugosh KL, McLellan AT, Camilleri A, Woody GE, Lynch KG. Prescription OxyContin abuse among patients entering addiction treatment. Am J Psychiatry 2007;164:1750–6.
Cooksey RW. Judgment analysis: Theory, methods, and applications. Cambridge: Academic Press, 1996.
Copeland J. A qualitative study of barriers to formal treatment among women who self-managed change in addictive behaviours. J Subst Abuse Treat 1997;14:183–90.
Cormier RA, Dell CA, Poole N. Women and substance abuse problems. BMC Womens Health 2004;4:S8.
Courtenay WH. Constructions of masculinity and their influence on men's well-being: a theory of gender and health. Soc Sci Med 2000;50:1385–401.
Cragg A, Hau JP, Woo SA, Kitchen SA, Liu C, Doyle-Waters MM, Hohl CM. Risk factors for misuse of prescribed opioids: a systematic review and meta-analysis. Ann Emerg Med 2019;74:634–46.
Daravula D. Gender, risk, and stereotypes. J Risk Uncertainty 2007;35:265–83.
Dorflinger L, Moore B, Goulet J, Becker W, Heapy AA, Sellinger JJ, Kerns RD. A partnered approach to opioid management, guideline concordant care and the stepped care model of pain management. J Gen Intern Med 2014;29:870–6.
Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR Recomm Rem 2016;65:1–49.
Ducharme J, Moore S. Opioid use disorder assessment tools and drug screening. MO Med 2019;116:318–24.
Geirsson M, Hensing G, Spak F. Does gender matter? A vignette study of general practitioners' management skills in handling patients with alcohol-related problems. Alcohol Alcohol 2009;44:620–5.
Green TC, Grimes Serrano JM, Licari A, Budman SH, Butler SF. Women who abuse prescription opioids: findings from the Addiction Severity Index-Multimedia Version Connect prescription opioid database. Drug Alcohol Depend 2009;103:65–73.
Green J. Risk and misfortune: the social construction of accidents. London: UCL Press, 1997.
Greenfield SF, Back SE, Lawson K, Brady KT. Substance abuse in women. Psychiatr Clin North Am 2010;33:339–55.
Greenfield SF, Brooks AJ, Gordon SM, Green CA, Kropp F, McHugh RK, Lincoln M, Hien D, Miele GM. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend 2007;86:1–21.
Hah JM, Sturgeon JA, Zocca J, Sharifzadeh Y, Mackey SC. Factors associated with prescription opioid misuse in a cross-sectional cohort of patients with chronic non-cancer pain. J Pain Res 2017;10:979–87.
Hirsh AT, Alqudah AF, Stutts LA, Robinson ME. Virtual human technology: capturing sex, race, and age influences in individual pain decision policies. PAIN 2008;140:231–8.
Hirsh AT, Anastas TM, Miller MM, Quinn PD, Kroenke K. Patient race and opioid misuse history influence provider risk perceptions for future opioid-related problems. Am Psychol 2020;75:784–95.
Hirsh AT, Hollingshead NA, Bair MJ, Matthias MS, Kroenke K. Preferences, experience, and attitudes in the management of chronic pain and depression: a comparison of physicians and medical students. Clin J Pain 2014;30:766–74.
Hirsh AT, Hollingshead NA, Ashburn-Nardo L, Kroenke K. The interaction of patient race, provider bias, and clinical ambiguity on pain management decisions. J Pain 2015;16:558–68.
Hirsh AT, Hollingshead NA, Bair MJ, Matthias MS, Wu J, Kroenke K. The influence of patient's sex, race and depression on clinician pain treatment decisions. Eur J Pain 2013;17:1569–79.
Hirsh AT, Miller MM, Hollingshead NA, Anastas T, Carnell ST, Lok BC, Chu C, Zhang Y, Robinson ME, Kroenke K, Ashburn-Nardo L. A randomized controlled trial testing a virtual perspective-taking intervention to reduce race and socioeconomic status disparities in pain care. PAIN 2019;160:2229–40.
Hollingshead NA, Matthias MS, Bair MJ, Hirsh AT. Impact of race and sex on pain management by medical trainees: a mixed methods pilot study of decision making and awareness of influence. Pain Med 2015;16:280–90.
Huang B, Dawson DA, Stinson FS, Hasin DS, Ruan WJ, Saha TD, Smith SM, Goldstein BB, Grant BF. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: results of the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2006;67:1062–73.
Inciardi JA, Surratt HL, Lugo Y, Cicero TJ. The diversion of prescription opioid analgesics. L Enforc Exec Forum 2007;7:127–41.
Ives TJ, Chelminski PR, Hannett-Stabler CA, Malone RS, Perhac JS, Potisek NM, Shilliday BB, DeWalt DA, Pignone MP. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res 2006;6:46.
Jadack RA, Hyde JS, Keller ML. Gender and knowledge about HIV, risky sexual behavior, and safer sex practices. Res Nurs Health 1995;18:313–16.
Jamison RN, Sheehan KA, Scanlan E, Matthews M, Ross EL. Beliefs and attitudes about opioid prescribing and chronic pain management: survey of primary care providers. J Opioid Manag 2014;10:375–82.
Kanoff RB. Intraspinal delivery of opiates by an implantable, programmable pump in patients with chronic, intractable pain of nonmalignant origin. J Am Osteopath Assoc 1994;94:487–93.
Kerridge BT, Saha TD, Chou SP, Zhang H, Jung J, Ruan WJ, Smith SM, Huang B, Hasin DS. Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions—III. Drug Alcohol Depend 2015;156:47–56.
Leichtling GJ, Irvine JM, Hildebran C, Cohen DJ, Hallvik SE, Deyo RA. Clinicians' use of prescription drug monitoring programs in clinical practice and decision-making. Pain Med 2017;18:1063–9.
Marel C, Sunderland M, Mills KL, Slade T, Teesson M, Chapman C. Conditional probabilities of substance use disorders and associated risk factors: progression from first use to use disorder on alcohol, cannabis, stimulants, sedatives and opioids. Drug Alcohol Depend 2019;194:136–42.
McCabe SE, Teter CJ, Boyd CJ. Illicit use of prescription pain medication among college students. Drug Alcohol Depend 2005;77:37–47.
McQuay HJ, Jadad AR, Carroll D, Faura C, Glynn CJ, Moore RA, Liu Y. Opioid sensitivity of chronic pain: a patient‐controlled analgesia method. Anaesthesia 1992;47:757–67.
Moynihan C. Theories in health care and research. Theories in masculinity. Br Med J 1998;317:1072.
Muzyk A, Smothers ZPW, Akrobetu D, Veve JR, MacEachern M, Tetrault JM, Gruppen L. Substance use disorder education in medical schools: a scoping review. Acad Med 2019;94:1825–34.
National Institute on Drug Abuse. Sex and gender differences in substance use. Available at: https://www.drugabuse.gov/publications/research-reports/substance-use-in-women/sex-gender-differences-in-substance-use . Accessed June 17, 2020.
Nelson-Zlupko L, Kauffman E, Dore MM. Gender differences in drug addiction and treatment: implications for social work intervention with substance-abusing women. Soc Work 1995;40:45–54.
Padayachee A. The hidden health burden: alcohol-abusing women, misunderstood and mistreated. Int J Drug Pol 1998;9:57–62.
Portenoy RK. Chronic opioid therapy in nonmalignant pain. J Pain Symptom Manage 1990;5:S46–62.
Purcell N, Zamora K, Gibson C, Tighe J, Chang J, Grasso J, Seal KH. Patient experiences with integrated pain care: a qualitative evaluation of one VA's biopsychosocial approach to chronic pain treatment and opioid safety. Glob Adv Health Med 2019;8:2164956119838845.
Raftery KA, Smith-Coggins R, Chen AH. Gender-associated differences in emergency department pain management. Ann Emerg Med 1995;26:414–21.
Samuelsson E. Substance use and treatment needs: constructions of gender in Swedish addiction care. Contemp Drug Probl 2015;42:188–208.
Schäfer G, Prkachin KM, Kaseweter KA, Williams AC. Health care providers' judgments in chronic pain: the influence of gender and trustworthiness. PAIN 2016;157:1618–25.
Schug SA, Merry AF, Acland RH. Treatment principles for the use of opioids in pain of nonmalignant origin. Drugs 1991;42:228–39.
Seal KH, Rife R, Li Y, Gibson C, Tighe J. Opioid reduction and risk mitigation in VA primary care: outcomes from the integrated pain team initiative. J Gen Intern Med 2020;35:1238–44.
Simoni-Wastila L, Ritter G, Strickler G. Gender and other factors associated with the nonmedical use of abusable prescription drugs. Subst Use Misuse 2004;39:1–23.
Sorsdahl K, Stein DJ, Myers B. Negative attributions towards people with substance use disorders in South Africa: variation across substances and by gender. BMC Psychiatry 2012;12:101.
Substance Abuse and Mental Health Services. Results from the 2016 National Survey on Drug Use and Health: Detailed Tables. 2017. Availale at: https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2016/NSDUH-DetTabs-2016.pdf%20%20%20 . Accessed June 17, 2020.
Substance Abuse and Mental Health Services. Treatment episode data set (TEDS): 2004-2014. National admissions to substance abuse treatment services, In BHSIS series S-84, HHS publication no. (SMA). Rockville: Center for Behavioral Health Statistics and Quality, 2016. Available at: https://wwwdasis.samhsa.gov/dasis2/teds_pubs/2014_teds_rpt_natl.pdf . Accessed June 17, 2020.
Tait RC, Chibnall JT, Kalauokalani D. Provider judgments of patients in pain: seeking symptom certainty. Pain Med 2009;10:11–34.
Tetrault JM, Desai RA, Becker WC, Fiellin DA, Concato J, Sullivan LE. Gender and non‐medical use of prescription opioids: results from a national US survey. Addiction 2008;103:258–68.
Thom B. Risk-taking behaviour in men: Substance use and gender. London: Health Development Agency, 2003.
Tuchman E. Women and addiction: the importance of gender issues in substance abuse research. J Addict Dis 2010;29:127–38.
Turk DC, Swanson KS, Gatchel RJ. Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain 2008;24:497–508.
Wandner LD, George SZ, Lok BC, Torres CA, Chuah JH, Robinson ME. Pain assessment and treatment decisions for virtual human patients. Cyberpsychol Behav Soc Netw 2013;16:904–9.
Wasan AD, Wootton J, Jamison RN. Dealing with difficult patients in your pain practice. Reg Anesth Pain Med 2005;30:184–92.
Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med 2005;6:432–42.
Webster LR. Risk factors for opioid-use disorder and overdose. Anesth Analg 2017;125:1741–8.
Wigton RS. Social judgement theory and medical judgement. Think Reason 1996;21:175–90.
Zenz M, Strumpf M, Tryba M. Long-term oral opioid therapy in patients with chronic nonmalignant pain. J Pain Symptom Manage 1992;7:69–77.
Zhang L, Losin E, Ashar YK, Koban L, Wager TD. Gender biases in estimation of others' pain. J Pain 2021;S1526-5900(21)00035-3. doi: 10.1016/j.jpain.2021.03.001. Online ahead of print.
doi: 10.1016/j.jpain.2021.03.001